1. Home
  2. THG vs GRFS Comparison

THG vs GRFS Comparison

Compare THG & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THG
  • GRFS
  • Stock Information
  • Founded
  • THG 1852
  • GRFS 1940
  • Country
  • THG United States
  • GRFS Spain
  • Employees
  • THG N/A
  • GRFS N/A
  • Industry
  • THG Property-Casualty Insurers
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • THG Finance
  • GRFS Health Care
  • Exchange
  • THG Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • THG 6.1B
  • GRFS 6.2B
  • IPO Year
  • THG 1995
  • GRFS 2006
  • Fundamental
  • Price
  • THG $167.00
  • GRFS $10.10
  • Analyst Decision
  • THG Buy
  • GRFS Hold
  • Analyst Count
  • THG 9
  • GRFS 1
  • Target Price
  • THG $179.00
  • GRFS $10.30
  • AVG Volume (30 Days)
  • THG 260.5K
  • GRFS 1.1M
  • Earning Date
  • THG 07-30-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • THG 2.16%
  • GRFS N/A
  • EPS Growth
  • THG 167.70
  • GRFS N/A
  • EPS
  • THG 12.02
  • GRFS 0.31
  • Revenue
  • THG $6,289,500,000.00
  • GRFS $7,968,532,207.00
  • Revenue This Year
  • THG $4.98
  • GRFS $7.14
  • Revenue Next Year
  • THG $6.17
  • GRFS $7.16
  • P/E Ratio
  • THG $13.91
  • GRFS $41.40
  • Revenue Growth
  • THG 3.09
  • GRFS 10.76
  • 52 Week Low
  • THG $130.48
  • GRFS $6.19
  • 52 Week High
  • THG $178.68
  • GRFS $10.30
  • Technical
  • Relative Strength Index (RSI)
  • THG 51.60
  • GRFS 67.23
  • Support Level
  • THG $163.18
  • GRFS $9.66
  • Resistance Level
  • THG $168.90
  • GRFS $10.30
  • Average True Range (ATR)
  • THG 2.96
  • GRFS 0.26
  • MACD
  • THG 0.36
  • GRFS 0.00
  • Stochastic Oscillator
  • THG 76.04
  • GRFS 85.19

About THG Hanover Insurance Group Inc

The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business internationally through a wholly owned subsidiary, Chaucer Holdings Limited, domiciled in the United Kingdom. The company conducts business operations through four operating segments: Core Commercial, Specialty, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: